“The Study (Tuberculosis Working to Empower Nations’ Diagnostic Efforts (TWENDE)) is granted approval for implementation”, wrote the Kenya Medical Research Institute (KEMRI) Scientific and Ethics Review Unit (SERU) in a letter to the TWENDE Consortium dated 15th August 2016 and signed by Mr. Ambrose Rachier, SERU Chairman.
This means, therefore, that SERU has approved to be conducted in Kenya the East Africa wide TWENDE research study. The Principal Investigator for TWENDE in Kenya is Dr. Evans Inyagala Amukoye. Ms. Norah Owaraga is the TWENDE Social Scientist and she will support the TWENDE Kenya Team as an advisor for the qualitative data collection, processing and analysis. Dr. Wilber Sabiiti is the TWENDE Team Leader.
Read more on TWENDE:
Photo: TWENDE Researchers, including Dr. Helen Meme of KEMRI actively participating in the TWENDE Knowledge Transfer Workshop that was held in Arusha, Tanzania on 2nd July 2016.
Since January 2016, CPAR is implementing a research on Tuberculosis (TB) code-named: “Tuberculosis:...More detail
In 2016, CPAR began its Policy Advocacy Programmes in which it functions as a Consulting Organisation....More detail